Project Grant R01MH140750
Award Date 9/1/26
Completion Date 5/31/31
Dollars Obligated $447K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- The National Institute of Mental Health awarded Emory University $781,081 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct the Pharmacy-Based LAI ART Versus Clinic Effectiveness (PLACE) study, a five-year research project examining long-acting injectable antiretroviral therapy delivery through pharmacies as an alternative to HIV clinics. The study addresses retention and viral suppression barriers in HIV treatment, particularly racial inequities...
- The National Institute of Mental Health awarded the University of Washington $729,551 on May 4, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate pharmacy-based HIV pre-exposure prophylaxis (PrEP) services, training, and financial models. The project addresses barriers to PrEP access by expanding pharmacists' capacity to prescribe and dispense PrEP independently, overcoming clinic distance and stigma that limit treatment uptake and continuity. Three...
- The National Institute of Mental Health awarded The Regents of the University of California, San Francisco $186,970 on August 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support research on HIV prevention strategies for adolescent girls and young women in Africa. The research quantifies unmet need for pre-exposure prophylaxis (PrEP) using demographic and health survey data from 21 countries, projects the impact of newer biomedical HIV prevention products...
- The National Institute of Mental Health awarded The Johns Hopkins University $1.995 million on June 10, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a national study assessing the reach and public health impact of pharmacist-prescribed HIV pre-exposure prophylaxis (PrEP). The research evaluates where pharmacist-prescribed PrEP is occurring within states that permit it, which populations it reaches, and what population-level impacts it is having on HIV...
- The National Institute of Mental Health awarded The Regents of the University of California, San Francisco $186,142 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242, K01 award K01MH140630) to optimize delivery of biomedical HIV prevention for mobile men in fishing communities along Lake Victoria, Kenya. The project will develop tailored, evidence-based service delivery strategies to improve uptake and adherence to biomedical HIV prevention among fishermen, a key...
- The National Institute of Mental Health awarded Public Health Foundation Enterprises, Inc. (doing business as Heluna Health) $610,601 on August 26, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid effectiveness-implementation study testing innovative strategies to increase pre-exposure prophylaxis (PrEP) and doxycycline post-exposure prophylaxis (DoxPEP) uptake and persistence among users of the TakemeHome.org home HIV/STI self-testing platform. The...
- The National Institute of Mental Health awarded The Trustees of Columbia University in the City of New York $149,190 on August 9, 2026, under the Mental Health Research Grants program (CFDA 93.242) to characterize HIV pre-exposure prophylaxis (PrEP) need and use in Eswatini through data triangulation and novel epidemiological methods. The research will develop and compare machine learning models to predict which individuals could most benefit from PrEP in Eswatini, where adult HIV prevalence...
- The National Institute of Mental Health awarded the University of Washington $613,244 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a cluster randomized controlled trial addressing food insecurity and HIV outcomes among women living with HIV in Senegal. The research leverages agriculture and community engagement to improve HIV care outcomes in the Casamance region of southern Senegal, the area most severely affected by the HIV epidemic and facing the...
- The National Institute of Mental Health awarded the University of California, San Diego $441,215 on July 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to explore barriers and facilitators of HIV care and prevention service engagement among 18–45-year-old Black and Latinx sexual minority men in San Diego, San Bernardino, and Riverside Counties, California. The project investigates new intervention approaches to increase uptake and persistence of long-acting injectable...
- The National Institutes of Health Office of the Director awarded Fred Hutchinson Cancer Center $1,000,792 on September 12, 2025, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial testing telehealth-supported delivery of HIV pre- and post-exposure prophylaxis (PrEP and PEP) at private pharmacies in Kenya. The study will randomize 20 pharmacies across Kisumu and Homa Bay Counties in Western Kenya...